The latest update is out from Giant Biogene Holding Co. Ltd. ( (HK:2367) ).
Giant Biogene Holding Co., Ltd. reported a significant financial growth for the year ended December 31, 2024, with a 57.2% increase in revenue and a 42.4% rise in net profit compared to the previous year. The company announced a proposal to distribute both final and special dividends, reflecting its strong financial performance and commitment to returning value to its shareholders.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd. is a company incorporated in the Cayman Islands, operating in the biotechnology sector. The company focuses on the development and distribution of biotechnological products, with a significant market presence and a commitment to innovation in its field.
YTD Price Performance: 32.26%
Average Trading Volume: 3,305,466
Technical Sentiment Signal: Sell
Current Market Cap: HK$70.27B
See more data about 2367 stock on TipRanks’ Stock Analysis page.